Merck KGaA MKGAF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 24.65B | 24.30B | 23.85B | 23.51B | 23.09B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 24.65B | 24.30B | 23.85B | 23.51B | 23.09B |
| Cost of Revenue | 10.09B | 9.98B | 9.80B | 9.67B | 9.54B |
| Gross Profit | 14.57B | 14.32B | 14.04B | 13.85B | 13.55B |
| SG&A Expenses | 7.09B | 6.94B | 6.73B | 6.53B | 6.38B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -70.22M | -123.64M | 56.28M | -162.66M | 111.21M |
| Total Operating Expenses | 20.18B | 19.69B | 19.29B | 18.55B | 18.34B |
| Operating Income | 4.48B | 4.61B | 4.56B | 4.96B | 4.74B |
| Income Before Tax | 3.54B | 3.74B | 3.73B | 4.12B | 3.96B |
| Income Tax Expenses | 756.50M | 784.17M | 779.47M | 839.07M | 829.98M |
| Earnings from Continuing Operations | 2.78K | 2.95K | 2.95K | 3.28K | 3.13K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -16.68M | -15.43M | -7.28M | -4.66M | -12.64M |
| Net Income | 2.77B | 2.94B | 2.94B | 3.28B | 3.11B |
| EBIT | 4.48B | 4.61B | 4.56B | 4.96B | 4.74B |
| EBITDA | 6.60B | 6.65B | 6.51B | 6.59B | 6.33B |
| EPS Basic | 6.37 | 6.76 | 6.76 | 7.54 | 7.16 |
| Normalized Basic EPS | 6.23 | 6.51 | 6.51 | 6.92 | 6.67 |
| EPS Diluted | 6.37 | 6.76 | 6.76 | 7.54 | 7.16 |
| Normalized Diluted EPS | 6.23 | 6.51 | 6.51 | 6.92 | 6.67 |
| Average Basic Shares Outstanding | 1.74B | 1.74B | 1.74B | 1.74B | 1.74B |
| Average Diluted Shares Outstanding | 1.74B | 1.74B | 1.74B | 1.74B | 1.74B |
| Dividend Per Share | 2.56 | 2.56 | 2.56 | 2.35 | 2.35 |
| Payout Ratio | 43.61% | 38.91% | 39.98% | 35.84% | 37.74% |